The numbers are still raw. Over the past seven days, Kalshi’s crypto perpetuals have clocked a notional trading volume north of $1 billion—a figure that, by any standard in the regulated derivatives space, is a lightning strike. But the real earthquake is still rumbling beneath the surface. On August 18, the CFTC-regulated platform filed for permission to list stock index perpetuals—a product that, if approved, would directly challenge the century-old franchise of CME Group and Cboe Global Markets. The market’s immediate reaction? CME shares up 1.26%, Cboe up 0.12%. Traditional finance yawned. But I’ve been chasing alpha through the fog of ICO whispers long enough to know that when incumbents sue regulators, the yawning is a mask. CME has already filed a lawsuit against the CFTC over Kalshi’s crypto perpetual approval—a move that reeks of fear, not confidence. This is the story of how a prediction market startup is quietly mapping the liquidity veins of the entire derivatives ecosystem, and why the sleeping giants are waking up.
Context: From Prediction Markets to the Perpetual Frontier Kalshi started as a niche platform for betting on election outcomes and economic indicators—a regulated alternative to Polymarket. But the ambition was never confined to binary events. The company, founded in 2018, has been steadily pivoting from prediction markets toward a multi-asset, regulated derivatives exchange. In May 2025, the CFTC approved Kalshi’s first crypto perpetual swap product, which went live in June. Within a week, the platform reported $1 billion in notional volume. By August, Kalshi had already filed applications for gold, silver, copper, and now stock index perpetuals. The product is a “perpetual swap”—a derivative contract with no expiration date, using a funding rate mechanism to keep the contract price anchored to the underlying index. This mechanism is well-tested in crypto markets (BitMEX, Binance, dYdX), but its application to regulated U.S. stock indices is a first. The index for the proposed “US500” product is sourced from MerQube, a third-party index provider. The filing came on August 18, 2025, and the clock is now ticking on the CFTC’s decision. The industry backdrop is a global perpetual swap market that Kalshi itself cites as projected to exceed $90 trillion in notional volume by 2025—a figure that, while self-serving, hints at the size of the prize.
Core: The Architecture of Disruption Let’s get into the technical guts. Kalshi’s perpetual swaps are not blockchain-based smart contracts. They are centralized order-book products, cleared and settled by Kalshi’s own engine under CFTC oversight. This is critical: the technology is not DeFi, but a regulated, centralized matching engine with a funding rate mechanism. The funding rate—a periodic payment between long and short positions—is the key innovation. It ensures that the perpetual contract price tracks the spot index without the need for expiry. In crypto, this mechanism has worked for years, but the asset class is volatile and retail-driven. Transferring it to U.S. stock indices, where volatility is lower and institutional participation dominates, introduces new risks. For one, the funding rate may not generate enough trading interest if the underlying index is range-bound. For another, the reliance on MerQube for real-time index data creates a single point of failure. If the data feed goes dark, the product freezes. Based on my experience auditing crypto derivatives, this is a non-trivial operational risk. The $1 billion weekly volume for crypto perpetuals is a signal of technical capability—the matching engine, risk management, and liquidation systems have passed a market test. But stock indices are a different beast. The liquidity profile is deeper, but the volatility is lower. The spread between bid and ask may be wider, and the funding rate may need to be subsidized by market makers initially. Kalshi’s team has not disclosed the fee structure, margin requirements, or funding rate algorithm for the proposed product. This lack of transparency is concerning. However, the fact that Kalshi successfully launched crypto perpetuals within weeks of CFTC approval suggests a high degree of technical readiness. The real bottleneck is not technology—it’s regulatory politics.
Market Dynamics: The $90 Trillion Elephant The global perpetual swap market is dominated by crypto exchanges, but the size is staggering. Kalshi’s projection of $90 trillion by 2025 is likely inflated, but even a fraction of that represents a massive opportunity. The traditional futures market is dominated by CME Group and Cboe, which offer standard futures and mini-E-mini contracts with fixed expiration dates. Kalshi’s perpetuals offer 24/7 trading, no expiry, and a retail-friendly interface. The target demographic is not the institutional behemoth that clears $100 million notional per trade; it’s the retail trader who wants to speculate on the S&P 500 without rolling over contracts every quarter. The $1 billion weekly volume for crypto perpetuals suggests that Kalshi has already captured a decent chunk of the crypto-native retail flow. If stock index perpetuals are approved, the addressable market expands to include traditional retail investors who are comfortable with regulated products but want the flexibility of perpetuals. The immediate competitive impact on CME and Cboe is likely to be small—their institutional clients are sticky, and the cost of switching is high. But the marginal loss of retail volume could be significant over time. The fact that CME has already sued the CFTC over Kalshi’s crypto perpetual approval indicates that the incumbents see the long-term threat. The lawsuit is a classic regulatory rent-seeking move: try to block the product through legal means rather than improve your own offering. The market’s muted reaction to the news—CME up 1.26%, Cboe up 0.12%—suggests that investors are not yet pricing in this threat. But I’ve seen this pattern before. When a new entrant starts hitting volume milestones, the market re-prices incumbents with a lag. The contrarian play here is to watch for a sustained build-up in Kalshi’s volume, which would trigger a reassessment of CME’s franchise value.
Regulatory Chessboard: The CFTC in the Crossfire The regulatory landscape is the most critical variable. Kalshi’s stock index perpetual application is pending before the CFTC, which has already approved the crypto perpetual product. But the CME lawsuit complicates the picture. The suit argues that the CFTC’s approval of Kalshi’s crypto perpetuals was improper—potentially because it encroaches on CME’s existing market for futures contracts. The legal basis of the suit is not fully disclosed, but the implication is clear: if the court rules against the CFTC, it could set a precedent that blocks or delays the stock index perpetual application. The risk is binary. If the CFTC approves the product, Kalshi gains a first-mover advantage in a new asset class. If the court sides with CME, Kalshi’s entire perpetual product line could be in jeopardy. The CFTC’s track record under the current administration has been moderately pro-innovation, but the political pressure from traditional exchanges is intense. The approval of crypto perpetuals was a signal that the CFTC is willing to expand the derivatives market beyond traditional players. The stock index application is a test of how far that willingness goes. The CFTC will likely require additional safeguards against market manipulation, given that the underlying indices are heavily influenced by a few large stocks. Kalshi may need to implement enhanced surveillance and position limits. The timeline for a decision is uncertain, but typically the CFTC takes 60-90 days for new product filings. The clock started on August 18. The CME lawsuit adds a layer of uncertainty that could stretch the timeline. The legal proceedings could take months, and the outcome is unpredictable. This is the highest risk factor for Kalshi and for the narrative.
Contrarian Angle: The Unspoken Risks The market’s narrative is that Kalshi is a disruptor, and the incumbents are dinosaurs. But the contrarian angle is more nuanced. The $1 billion weekly volume for crypto perpetuals is impressive, but it is unaudited and could be inflated by early adopter hype. The product is only a month old; the real test will come when the market turns bearish. In crypto, perpetuals have a history of explosive liquidation cascades. Kalshi’s risk management system is untested in a stress scenario. Another blind spot is the reliance on a single index provider, MerQube. If the data feed is interrupted or manipulated, the product could be forced into a halt. The CFTC’s approval process for the stock index product will likely require multiple data sources, but that adds cost and complexity. The funding rate mechanism, while elegant, may not work well for low-volatility indices. If the funding rate is too low, traders will not be incentivized to take the other side, leading to persistent deviations from the index. Kalshi may need to subsidize the funding rate, which would eat into profits. The company’s revenue model is not disclosed, but it likely relies on trading fees and funding rate income. The $1 billion volume figure does not translate directly into revenue—the fee rate is probably a few basis points at most. The commercial viability of Kalshi’s model is still unproven. The contrarian take is that the market is overestimating the speed of disruption. CME and Cboe are not sitting still. They can launch their own perpetual products or lobby the CFTC for stricter rules. The incumbents have deep pockets and strong relationships. Kalshi’s lead is fragile. The real story is not the $1 billion volume; it’s the regulatory and legal battle that will determine whether Kalshi becomes a permanent fixture or a footnote.
Takeaway: The Next Watch The next 90 days will be decisive. Watch for the CFTC’s public comment period on the stock index perpetual filing. Watch for any rulings in the CME vs. CFTC lawsuit. If the CFTC approves the product without major restrictions, Kalshi will have a clear runway to expand into the retail derivatives market. If the court blocks or delays, the narrative of disruption will stall. The price action of CME and Cboe shares will be the ultimate barometer. I’m not betting on the outcome yet. But I’m watching the liquidity veins—and they’re starting to pulse.
Chasing the alpha through the fog of ICO whispers — David Brown, Crypto News Aggregator Operator
